Relay Therapeutics, Inc. (NASDAQ: RLAY) reported Q3 EPS of ($0.43), $0.01 worse than the analyst estimate of ($0.42).

For earnings history and earnings-related data on Relay Therapeutics, Inc. (RLAY) click here.